References
- Kilian JG, Kerr K, Lawrence C, Celermajer DS. Myocarditis and cardiomyopathy associated with clozapine. Lancet 1999; 354: 1841–1845.
- Ronaldson KJ, Taylor AJ, Fitzgerald PB, Topliss DJ, Elsik M, McNeil JJ. Diagnostic characteristics of clozapine induced myocarditis identified by an analysis of 38 cases and 47 controls. J Clin Psych 2010; 71:976–981.
- Ronaldson KJ, Taylor AJ, Fitzgerald PB, Topliss DJ, McNeil JJ. Clinical course and analysis of ten fatal cases of clozapine-induced myocarditis and comparison with 66 surviving cases. Schizophr. Res. 2011;doi:10.1016/j.schres.2011.01.017.
- Hill GR, Harrison-Woolrych M. Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Programme. N Z Med J 2008; 121:68–74.
- Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009; 373:31–41.
- Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009; 374:620–627.
- Merrill DB, Dec GW, Goff DC. Adverse cardiac effects associated with clozapine. J Clin Psychopharmacol 2005; 25:32–41.
- Brady WJ, Ferguson JD, Ullman EA, Perron AD. Myocarditis: emergency department recognition and management. Emerg Med Clin North Am 2004; 22:865–885.
- Batra AS, Lewis AB. Acute myocarditis. Curr Opin Pediatr 2001; 13:234–239.
- Lee C-H, Tsai W-C, Hsu C-H, Liu P-Y, Lin L-J, Chen J-H. Predictive factors of a fulminant course in acute myocarditis. Int J Cardiol 2006; 109:142–145.
- Kato S, Morimoto S-I, Hiramitsu S . Risk factors for patients developing a fulminant course with acute myocarditis. Circ J 2004; 68:734–739.
- Cooper LT. Myocarditis. New Engl J Med 2009; 360: 1526–1538.
- Sabatine MS, Poh K-K, Mega JL, Shepard J-AO, Stone JR, Frosch MP. Case 36-2007: a 31-year-old woman with rash, fever, and hypotension. New Engl J Med 2007; 357:2167–2178.
- Berk M, Fitzsimons J, Lambert T . Monitoring the safe use of clozapine: a consensus view from Victoria, Australia. CNS Drugs 2007; 21:117–127.
- Al Ali AM, Straatman LP, Allard MF, Ignaszewski AP. Eosinophilic myocarditis: case series and review of literature. Can J Cardiol 2006; 22:1233–1237.